• About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, April 11, 2021
amarhealth.com
Advertisement
  • Home
  • Kids Corner
  • Country wide health
  • Pharmaceuticals
  • Amar Doctor
  • Celebrity Health
  • Health Tips
  • More
    • Good News
    • Spot Light
    • Health Crime
    • Write up
    • Environment health
    • Health Institute
Bangla Site
  • Home
  • Kids Corner
  • Country wide health
  • Pharmaceuticals
  • Amar Doctor
  • Celebrity Health
  • Health Tips
  • More
    • Good News
    • Spot Light
    • Health Crime
    • Write up
    • Environment health
    • Health Institute
Bangla Site
amarhealth.com

 Bangla Site 

Home Breaking news

AstraZeneca says Covid-19 vaccine 76 percent effective in new analysis, to seek US approval

March 25, 2021
in Breaking news, Good News, Pharmaceuticals
AstraZeneca says Covid-19 vaccine 76 percent effective in new analysis, to seek US approval
2.5k
VIEWS
Share on FacebookShare on LinkedinShare on Twitter

Health Desk – 25 Mar, 2021: AstraZeneca’s said its Covid-19 vaccine was 76 percent effective in a new analysis of its US trial – only a tad lower than the level in an earlier report this week criticised for using outdated data.

Interim data published on Monday had put the vaccine’s efficacy rate at 79 percent but had not included more recent infections, leading to a highly unusual public rebuke from US health officials.

The small revision to the efficacy rate will go a long way to putting the vaccine back on track for gaining US emergency use authorisation – which it plans to seek in the coming weeks – and help AstraZeneca in its efforts to dispel doubts about its effectiveness and side-effects, independent experts said.

AstraZeneca also reiterated that the shot, developed with Oxford University, was 100 percent effective against severe or critical forms of the disease. There have been eight severe cases – all among trial participants who received the placebo.

“The vaccine efficacy against severe disease, including death, puts the AZ vaccine in the same ballpark as the other vaccines,” said William Schaffner, an infectious disease expert from the Vanderbilt University School of Medicine, adding that he expects the shot to gain US approval.

The latest data was based on 190 infections among more than 32,400 participants in the United States, Chile and Peru. The earlier interim data was based on 141 infections through February 17.

It also said the vaccine showed 85 percent efficacy in adults 65 years and older, higher than the 80 percent rate reported on Monday.

AstraZeneca said the latest data has been presented to the independent trial oversight committee, the Data Safety Monitoring Board, and it plans to submit the analysis for peer-reviewed publication in the coming weeks.

“The primary analysis is consistent with our previously released interim analysis, and confirms that our Covid-19 vaccine is highly effective in adults,” Mene Pangalos, executive vice president of BioPharmaceuticals R&D at AstraZeneca said in a statement.

The drugmaker noted there were 14 additional possible or probable cases to be analysed so numbers in later updates of the trial results may fluctuate slightly.

The updated 76 percent efficacy rate compares with rates of about 95 percent for vaccines from Pfizer/BioNTech and Moderna in their trial data.

Experts have noted, however, that AstraZeneca’s latest data is particularly significant because it was compiled after more infectious variants of the coronavirus became prevalent.

“This appears to be a very effective vaccine with no safety concerns,” said Paul Griffin, a professor at the University of Queensland.

“Hopefully, this should now give people the confidence that this vaccine is the right one to continue to use moving forward,” he said, adding that he and his parents have received the vaccine.

AstraZeneca’s vaccine is seen as crucial in tackling the spread of Covid-19 across the globe, not just due to limited supply of vaccines but also because it is easier and cheaper to transport than rival shots. It has been granted conditional marketing or emergency use authorisation in more than 70 countries.

The vaccine, once hailed as a milestone in the fight against the Covid-19 pandemic, has been dogged by questions since late last year when the drugmaker and Oxford University published data from an earlier trial with two different efficacy readings as a result of a dosing error.

Then this month, more than a dozen countries temporarily suspended giving out the vaccine after reports linked it to a rare blood clotting disorder in a very small number of people.

The European Union’s drug regulator said last week the vaccine was clearly safe, but Europeans remain sceptical about its safety.

Canada on Wednesday said it was safe but added a warning to the vaccine’s label about rare blood clots.

Its rollout has also been marred by production glitches and export curbs imposed by India and the European Union, threatening to slow global efforts to end the pandemic which has killed more than 2.8 million.

Previous Post

Modi to bring 12 lakh doses of AstraZeneca vaccine as ‘gift’: Health DG

Next Post

AstraZeneca vaccine safe, no risk of blood clot, says Bangladeshi-British scientist

Next Post
AstraZeneca vaccine safe, no risk of blood clot, says Bangladeshi-British scientist

AstraZeneca vaccine safe, no risk of blood clot, says Bangladeshi-British scientist

Covid 19 vaccines: India to focus on domestic supply, will not ramp up export

Covid 19 vaccines: India to focus on domestic supply, will not ramp up export

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected test

  • 85 Followers
  • 113k Subscribers
  • 23k Followers
  • 99 Subscribers
  • Trending
  • Comments
  • Latest
Health Minister receives Covid-19 Vaccine

Health Minister receives Covid-19 Vaccine

February 7, 2021
More countries act against exposure to radon and associated cancer risks

More countries act against exposure to radon and associated cancer risks

February 5, 2021
WHO issues new guidelines on the management of chronic pain in children

WHO issues new guidelines on the management of chronic pain in children

January 28, 2021
MotoGP makes tyre strategies easier to follow for 2017

MotoGP makes tyre strategies easier to follow for 2017

January 11, 2021
Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

0
WHO, Sanofi renew collaboration to sustain elimination efforts

WHO, Sanofi renew collaboration to sustain elimination efforts

0
Oxford/AstraZeneca Covid vaccine ‘dose error’ explained

Oxford/AstraZeneca Covid vaccine ‘dose error’ explained

0
Hackers steal vaccine data in Europe, companies say

Hackers steal vaccine data in Europe, companies say

0
Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

April 10, 2021
Akram tests positive for Covid-19

Akram tests positive for Covid-19

April 10, 2021
Strict lockdown from April 14

Strict lockdown from April 14

April 10, 2021
Mumbai in lockdown as Indian vaccines run short

Mumbai in lockdown as Indian vaccines run short

April 10, 2021

Recent News

Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

April 10, 2021
Akram tests positive for Covid-19

Akram tests positive for Covid-19

April 10, 2021
Strict lockdown from April 14

Strict lockdown from April 14

April 10, 2021
Mumbai in lockdown as Indian vaccines run short

Mumbai in lockdown as Indian vaccines run short

April 10, 2021
amarhealth.com

Editor: Dr Apurba Pandit

Executve Editor: Mahfuzur Rahman


Office: 65 Mymensingh Lane (6th Floor), Banglamotor, Dhaka.
Phone: 01711345029
Email: newsamarhealth@gmail.com

Follow Us

Browse by Category

  • Amar Doctor
  • Breaking news
  • Celebrity Health
  • Country wide health
  • Environment health
  • Good News
  • Health Crime
  • Health Institute
  • Health Tips
  • Kids Corner
  • Pharmaceuticals
  • Spot Light
  • Uncategorized
  • Write up

Registration of online portal

Recent News

Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

Number of daily Covid-19 casualties breaks record again; 77 dead, 5,343 infected

April 10, 2021
Akram tests positive for Covid-19

Akram tests positive for Covid-19

April 10, 2021
  • About
  • Advertise
  • Privacy & Policy
  • Contact

Copyright © 2016. All rights reserved amarhealth.Com

No Result
View All Result
  • Kids Corner
  • Good News
  • Health Crime
  • Health Tips
  • Pharmaceuticals
  • Celebrity Health
  • Spot Light
  • Health Institute
  • Amar Doctor
  • Environment health
  • Country wide health
  • Write up

Copyright © 2016. All rights reserved amarhealth.Com